
Healthnotes Newswire (November 29, 2007)—Following reports of serious injuries and deaths in children treated with cold medicines, the health community and industry has waited expectantly for the US Food and Drug Administration to weigh in on the issue. The FDA’s announcement in August of its plans to conduct a hearing prompted many manufacturers to voluntarily remove children’s cold medicines from store shelves. Now, the much-anticipated hearing has led the FDA to conclude that, until more research is conducted that shows safety and efficacy, these medicines should not be given to children under two years old unless instructed by a healthcare provider.


